药效评价VPR-254: an inhibitor of ROR-gamma T with potential utility for the treatment of inflammatory bowel disease.
期刊:Inflammopharmacology发表年份:2020作者:Leo R Fitzpatrick; Jeff Small; Robert O'Connell; George Talbott; Gordon Alton; Jim Zapf
追踪行业前沿,洞察产业趋势